Phoenix-Micron Inc and ArtiKode Intelligence team up to enhance OCT imaging with AI


The collaboration will bring automated, AI-powered OCT segmentation to MICRON Software Suite.

Image credit: AdobeStock/Tony Baggett

(Image credit: AdobeStock/Tony Baggett)

Phoenix-Micron Inc has announced a collaboration with ArtiKode Intelligence to “to deliver enhanced, automated optical coherence tomography (OCT) segmentation and analysis capabilities to MICRON Software Suite.”1

ArtiKode Intelligence is a Valencia, Spain-based innovator in artificial intelligence (AI) and machine learning and a spin-out of the Computer Vision & Behaviour Analysis Lab at Universidad Politécnica de Valencia. The company stated they have developed advanced, performant, and accurate deep learning algorithms for ophthalmic image analysis based on their core research.

The algorithms from ArtiKode are currently being trained on a large dataset of rodent OCT scans from MICRON systems. These scans are being used to automate the detection and segmentation of up to eight distinct retinal layers. The collaboration will allow for the underlying AI model to be integrated directly into the MICRON OCT imaging workflow.

J. Scott Carr, CEO of Phoenix-Micron, Inc discussed the collaboration in a press release from the company.

"We are thrilled to partner with ArtiKode Intelligence to bring this transformative AI capability to our OCT product line," said Carr. "Harnessing the power of AI and deep learning within our core products is another key step in our mission to provide advanced ophthalmic research tools that help accelerate preclinical discoveries and advance the understanding of retinal health."

The companies plan to show the new AI-powered OCT segmentation feature at the upcoming ARVO 2024 conference in Seattle, WA, USA, while it will be generally available in the Fall 2024 release of MICRON Software Suite.

  1. Phoenix-Micron Enhances OCT Imaging with AI-powered OCT Segmentation. Press release; April 23, 2024. Accessed April 23, 2024.
© 2024 MJH Life Sciences

All rights reserved.